Dataset Information

Acute psychological impact on COVID-19 patients in Hubei: a multicenter observational study.

ABSTRACT: We conducted a multicentre cross-sectional survey of COVID-19 patients to evaluate the acute psychological impact on the patients with coronavirus disease 2019 (COVID-19) during isolation treatment based on online questionnaires from 2 February to 5 March 2020. A total of 460 COVID-19 patients from 13 medical centers in Hubei province were investigated for their mental health status using online questionnaires (including Patient Health Questionnaire-9, Generalized Anxiety Disorder-7, Patient Health Questionnaire-15, and Insomnia Severity Index scales). Among all 460 COVID-19 patients, 187 (40.65%) of them were healthcare workers (HCWs). 297 (64.57%) of them were females. The most common psychological problems were somatization symptoms (66.09%, n?=?304), followed by depression (53.48%, n?=?246), anxiety (46.30%, n?=?213), problems of insomnia (42.01%, n?=?171), and then self-mutilating or suicidal thoughts (23.26%, n?=?107). Of all the patients, 15.65% (n?=?72) had severe somatization symptoms, and 2.83% (n?=?13) had severe (almost every day) self-mutilating or suicidal thoughts. The most common psychological problems for HCWs were somatization symptoms (67.84%, n?=?125), followed by depression (51.87%, n?=?97), anxiety (44.92%, n?=?84), problems of insomnia (36.18%, n?=?55), and then self-mutilating or suicidal thoughts (20.86%, n?=?39). Patients with lower education levels were found to be associated with higher incidence of self-mutilating or suicidal thoughts (odds ratio [OR], 2.68, 95% confidence interval [95% CI], 1.66-4.33 [P?

SUBMITTER: Wang M

PROVIDER: S-EPMC7890099 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Acute psychological impact on COVID-19 patients in Hubei: a multicenter observational study.

Wang Minghuan M Hu Caihong C Zhao Qian Q Feng Renjie R Wang Qing Q Cai Hongbin H Guo Zhenli Z Xu Kang K Luo Wenjing W Guo Canshou C Zhang Sheng S Chen Chunfa C Zhu Chunli C Wang Hongmin H Chen Yu Y Ma Li L Zhan Peiyan P Cao Jie J Huang Shanshan S Yang Mia Jiming MJ Fang Yuxin Y Zhu Suiqiang S Yang Yuan Y

Translational psychiatry 20210218 1

We conducted a multicentre cross-sectional survey of COVID-19 patients to evaluate the acute psychological impact on the patients with coronavirus disease 2019 (COVID-19) during isolation treatment based on online questionnaires from 2 February to 5 March 2020. A total of 460 COVID-19 patients from 13 medical centers in Hubei province were investigated for their mental health status using online questionnaires (including Patient Health Questionnaire-9, Generalized Anxiety Disorder-7, Patient Hea ...[more]

PMID: 33602920

Similar Datasets

Project description:BackgroundIn the ongoing COVID-19 pandemic, the susceptibility of patients with rheumatic diseases to COVID-19 remains unclear. We aimed to investigate susceptibility to COVID-19 in patients with autoimmune rheumatic diseases during the ongoing COVID-19 pandemic.MethodsWe did a multicentre retrospective study of patients with autoimmune rheumatic diseases in Hubei province, the epicentre of the COVID-19 outbreak in China. Patients with rheumatic diseases were contacted through an automated telephone-based survey to investigate their susceptibility to COVID-19. Data about COVID-19 exposure or diagnosis were collected. Families with a documented history of COVID-19 exposure, as defined by having at least one family member diagnosed with COVID-19, were followed up by medical professionals to obtain detailed information, including sex, age, smoking history, past medical history, use of medications, and information related to COVID-19.FindingsBetween March 20 and March 30, 2020, 6228 patients with autoimmune rheumatic diseases were included in the study. The overall rate of COVID-19 in patients with an autoimmune rheumatic disease in our study population was 0·43% (27 of 6228 patients). We identified 42 families in which COVID-19 was diagnosed between Dec 20, 2019, and March 20, 2020, in either patients with a rheumatic disease or in a family member residing at the same physical address during the outbreak. Within these 42 families, COVID-19 was diagnosed in 27 (63%) of 43 patients with a rheumatic disease and in 28 (34%) of 83 of their family members with no rheumatic disease (adjusted odds ratio [OR] 2·68 [95% CI 1·14-6·27]; p=0·023). Patients with rheumatic disease who were taking hydroxychloroquine had a lower risk of COVID-19 infection than patients taking other disease-modifying anti-rheumatic drugs (OR 0·09 [95% CI 0·01-0·94]; p=0·044). Additionally, the risk of COVID-19 was increased with age (adjusted OR 1·04 [95%CI 1·01-1·06]; p=0·0081).InterpretationPatients with autoimmune rheumatic disease might be more susceptible to COVID-19 infection than the general population.FundingNational Natural Science Foundation of China and the Tongji Hospital Clinical Research Flagship Program.

Project description:BackgroundTo fight against COVID-19, many policymakers are wavering on stricter public health interventions. Examining the different strategies both in and out of China's Hubei province, which contained the epidemic in late February 2020, could yield valuable guidance for the management of future pandemics. This study assessed the response process and estimated the time-varying effects of the Hubei control strategy. Analysis of these strategies provides insights for the design and implementation of future policy interventions.MethodsWe retrospectively compared the spread and control of COVID-19 between China's Hubei (excluding Wuhan) and non-Hubei areas using data that includes case reports, human mobility, and public health interventions from 1 January to 29 February 2020. Static and dynamic risk assessment models were developed to statistically investigate the effects of the Hubei control strategy on the virus case growth after adjusting importation risk and policy response timing with the non-Hubei strategy as a control.ResultsThe analysis detected much higher but differential importation risk in Hubei. The response timing largely coincided with the importation risk in non-Hubei areas, but Hubei areas showed an opposite pattern. Rather than a specific intervention assessment, a comprehensive comparison showed that the Hubei control strategy implemented severe interventions characterized by unprecedentedly strict and 'monitored' self-quarantine at home, while the non-Hubei strategy included physical distancing measures to reduce contact among individuals within or between populations. In contrast with the non-Hubei control strategy, the Hubei strategy showed a much higher, non-linear and gradually diminishing protective effect with at least 3 times fewer cases.ConclusionsA risk-based control strategy was crucial to the design of an effective response to the COVID-19 outbreak. Our study demonstrates that the stricter Hubei strategy achieves a stronger controlling effect compared to other strategies. These findings highlight the health benefits and policy impacts of precise and differentiated strategies informed by constant monitoring of outbreak risk.

Dataset Information

Acute psychological impact on COVID-19 patients in Hubei: a multicenter observational study.

Publications

Acute psychological impact on COVID-19 patients in Hubei: a multicenter observational study.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets